Koroner Kollateral Gelişiminin Fizyolojisi ve Gelişim Mekanizmaları
Synopsis
Koroner kollateral dolaşım , koroner arter hastalığında tıkanma veya daralma olduğunda alternatif kan akımı sağlayarak miyokardın korunmasında kritik bir rol oynar. Bu dolaşım, doğal bir bypass işlevi görerek iskemik bölgelerde oksijen ve besin maddesi taşır. Koroner kollateral dolaşımın klinik önemi, özellikle akut miyokard enfarktüsünde ve kronik koroner arter hastalığında belirgindir. İyi gelişmiş kollateral dolaşım, kardiyak performansı korur, iskemiye bağlı hasarı sınırlar ve enfarktüs boyutunu küçültür.
Kollateral gelişimi, endotel hücrelerinin ve vasküler düz kas hücrelerinin katıldığı kompleks bir süreçtir. Bu süreçte, mekanik stres, hipoksi ve anjiyogenik faktörler gibi uyaranlar kollateral damarlanmayı tetikler. Özellikle vasküler endotelyal büyüme faktörü (VEGF) ve fibroblast büyüme faktörü (FGF) gibi moleküller kollateral arterlerin gelişiminde önemli rol oynar.
Kollateral dolaşımın klinikte değerlendirilmesi, genellikle anjiyografi ve invaziv yöntemlerle yapılır. Non-invaziv görüntüleme yöntemleri ise klinik pratikte giderek artan bir rol oynamaktadır. Kollateral akımın varlığı ve etkinliği, uzun vadede hastaların yaşam kalitesini ve sağkalım oranlarını artırabilir. Tedavi yaklaşımları açısından kollateral dolaşımı artırmak amacıyla farmakolojik ve cerrahi stratejiler araştırılmaktadır. Sonuç olarak, Koroner kollateral dolaşım, kalp krizi ve koroner arter hastalığı gibi durumlarda sağkalımı etkileyen önemli bir faktördür.
Coronary collateral circulation plays a critical role in protecting the myocardium by providing alternative blood flow in cases of coronary artery occlusion or stenosis. This circulation acts as a natural bypass, delivering oxygen and nutrients to ischemic regions. The clinical significance of coronary collateral circulation is particularly evident in acute myocardial infarction and chronic coronary artery disease. Well-developed collateral circulation preserves cardiac performance, limits ischemic damage, and reduces infarct size.
Collateral development is a complex process involving endothelial cells and vascular smooth muscle cells. Mechanical stress, hypoxia, and angiogenic factors act as stimuli for collateral vessel formation. Notably, molecules such as vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) play a key role in the development of collateral arteries.
The evaluation of collateral circulation in clinical settings is typically done using angiography and invasive methods, though non-invasive imaging techniques are increasingly being used in clinical practice. The presence and efficacy of collateral flow can improve long-term patient outcomes, enhancing quality of life and survival rates. In terms of treatment approaches, pharmacological and surgical strategies are being explored to enhance collateral circulation. In conclusion, coronary collateral circulation is an important factor influencing survival in conditions like heart attack and coronary artery disease.
References
Schaper, W., & Ito, W. D. (1996). Molecular mechanisms of coronary collateral vessel growth. Circulation Research, 79(5), 911-919.
Heil, M., & Schaper, W. (2004). Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circulation Research, 95(5), 449-458.
Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nature Medicine, 6(4), 389-395.
Arras, M., Ito, W. D., Scholz, D., Winkler, B., Schaper, J., & Schaper, W. (1998). Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. The Journal of Clinical Investigation, 101(1), 40-50.
Meier, P., Hemingway, H., Lansky, A. J., Knapp, G., Pitt, B., & Seiler, C. (2012). The impact of the coronary collateral circulation on mortality: a meta-analysis. European Heart Journal, 33(5), 614-621.
Rentrop, K. P., Cohen, M., Blanke, H., & Phillips, R. A. (1985). Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. Journal of the American College of Cardiology, 5(3), 587-592.
Zbinden, R., Zbinden, S., Meier, P., & Seiler, C. (2007). Coronary collateral flow in response to endurance exercise training. European Journal of Cardiovascular Prevention & Rehabilitation, 14(2), 250-257.
Silvestre, J. S., Smadja, D. M., & Lévy, B. I. (2013). Postischemic revascularization: from cellular and molecular mechanisms to clinical applications. Physiological Reviews, 93(4), 1743-1802.
Werner, G. S., & Ferrari, M. (2014). The future of collateral artery research. Current Cardiology Reviews, 10(1), 1-3.
Heil M, Eitenmüller I, Schmitz-Rixen T, Schaper W. Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med. 2006;10(1):45-55.
Altman JD, Bache RJ. The coronary collateral circulation. ACC Curr J Rev. 2001;10:20-25.
Schaper W. Tangential wall stress as a molding force in the development of collateral vessels in the canine heart. Experientia. 1967;23:595-596.
Schaper W, Schumacher B, Pecher P, von Specht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease. Circulation. 1998;97:645-650.
Schaper W, Nienaber C, Gottwik M. The importance of the collateral circulation for myocardial survival. Acta Med Scand. 1981;210(S651):29-35.
Wolfgang S, Scholz D. Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol. 2003;23(7):1143-1151.
Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001;49:507-521.
Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in dogs. Circulation. 1994;89:2183-2189.
Simons M. Angiogenesis, arteriogenesis, and diabetes: Paradigm reassessed? J Am Coll Cardiol. 2005;46(5):835-837.
Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005;16(2):159-178.
Yanagisawa-Miwa A, Uchida Y, Nakamura F, Nakagawa O, Tomaru K, Kido H, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 1992;257(5075):1401-1403.
van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation. 1997;95:1030-1037.
Schultz A, Lavie L, Hochberg I. Interindividual heterogeneity in the hypoxic regulation of VEGF: Significance for the development of collateral circulation. Cardiovasc Res. 1999;44(2):301-307.
Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, et al. Tie2 receptor ligands, angiopoietins, regulate vascular maturation by modulating endothelial cell survival and pericyte coverage. Mol Cell Biol. 1998;18(8):4283-4290.
Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6(4):389-395.
Ziche M, Parenti A, Ledda F, Dell'Era P, Granger HJ, Maggi CA, et al. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ Res. 1997;80:845-852.
Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA. 2001;98(5):2604-2609.
Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327(6122):524-526.
Papapetropoulos A, Garcia-Cardeña G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest. 1997;100(12):3131-3139.
Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101(11):2567-2578.
